Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs SACITUZUMAB GOVITECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs SACITUZUMAB GOVITECAN: Safety Overview

Metric ROZANOLIXIZUMAB SACITUZUMAB GOVITECAN
Total FAERS Reports 303 1,261
Deaths Reported 9 353
Death Rate 3.0% 28.0%
Hospitalizations 114 530
Average Patient Age 61.3 yrs 57.3 yrs
% Female Patients 60.9% 89.0%
Manufacturer UCB, Inc. Gilead Sciences, Inc.
Route SUBCUTANEOUS INTRAVENOUS